Test Price
450 AED✅ Home Collection Available
HIV Comprehensive Panel (HIV-1/2 Ag/Ab + Western Blot + WES Susceptibility) in UAE
Executive Summary & Core Metrics
Integrated Diagnostic & Genetic Susceptibility Assessment
Our HIV Comprehensive Panel combines 4th-generation CMIA for p24 antigen/antibody detection, confirmatory Western Blot, and Whole Exome Sequencing (WES) targeting CCR5Δ32 and related immune variants for genetic susceptibility profiling. All testing is performed at ISO 9001:2015 certified laboratories under strict DHA oversight, with results available same day when specimens are collected on Tuesday, Thursday, or Saturday by 9 AM.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM – 11 PM)
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This advanced comprehensive panel screens for HIV-1 and HIV-2 antigens and antibodies using fourth-generation chemiluminescent immunoassay (CMIA), confirms all reactive results with Western Blot, and evaluates host genetic susceptibility through Whole Exome Sequencing (WES) with targeted analysis of CCR5Δ32, CCR2-V64I, and SDF1-3'A variants. Designed for individuals seeking thorough evaluation—including those with high-risk exposure, unexplained immune dysregulation, or pre-exposure prophylaxis planning—the panel delivers a complete immunological and genetic risk profile in a single workflow.
How Our HIV Comprehensive Panel Compares
| Feature | Our HIV Comprehensive Panel | Standard Hospital HIV Test |
|---|---|---|
| Methodology | 4th Gen CMIA (p24 Ag/Ab) + Western Blot + Whole Exome Sequencing (WES) | 3rd Gen ELISA + Western Blot only |
| Speed | Same-day report (Tue/Thu/Sat collection by 9 AM) | 3–5 business days |
| Precision | 99.9% sensitivity & specificity; WES reveals genetic susceptibility | ~99.5% sensitivity; no genetic profile |
| Price (AED) | 450 | 300–400 |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
From a medical genetics standpoint, the integration of Whole Exome Sequencing into this comprehensive HIV panel enables detection of clinically significant variants such as CCR5Δ32 that influence viral entry and disease progression. A negative serological result after the appropriate window period provides robust reassurance; however, genetic susceptibility data offers lifelong insight into your immunological architecture. If you have experienced a high-risk exposure within the last 72 hours, please prioritise emergency department evaluation for post-exposure prophylaxis (PEP) rather than waiting for test results. Modern antiretroviral therapy ensures that an HIV diagnosis is a manageable condition, and our multidisciplinary team is committed to supporting you with confidentiality and compassion.
Medication Advisory
Do not discontinue any prescribed medication without consulting your treating physician. This panel analyses viral markers and genomic DNA independently of metabolic state; continue all medications as directed unless otherwise advised by your doctor.
Exclusion Criteria & Emergency Red Flags
- Not suitable for individuals with active severe infection requiring immediate medical intervention or those with known bleeding disorders incompatible with venipuncture.
- If you experience symptoms of acute retroviral syndrome—sudden high fever, diffuse maculopapular rash, severe pharyngitis, oral ulcers, cervical lymphadenopathy—proceed directly to the nearest emergency department; do not wait for test results.
- This panel is not a substitute for urgent PEP evaluation. If potential exposure occurred within 72 hours, visit an emergency room immediately for risk assessment and possible antiviral initiation.
Patient FAQ & Clinical Guidance
1. How soon after exposure can this comprehensive HIV panel detect infection?
The panel can detect infection as early as 10–14 days post-exposure using the p24 antigen component of the 4th-generation CMIA, with definitive serological confirmation at 4 weeks via Western Blot. The Whole Exome Sequencing susceptibility results are independent of window period timing and can be obtained at any time, providing lifelong genetic insight.
2. Is the Whole Exome Sequencing component necessary or optional?
Whole Exome Sequencing is included as a standard, integral component of this comprehensive panel, not as an optional add-on. It identifies genetic variants—such as CCR5Δ32, CCR2-V64I, and SDF1-3'A—that correlate with resistance or heightened susceptibility to HIV infection, delivering a complete immunological and genetic profile that extends well beyond routine serological screening.
3. Do I need to fast or stop medications before sample collection?
No fasting is required. Continue all prescribed medications unless your physician specifically advises otherwise. The panel analyses viral antigens, antibodies, and genomic DNA independently of metabolic state, so fasting is not necessary for accurate results.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Governance
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data—including genetic sequencing results—are encrypted, access-controlled, and processed exclusively within UAE jurisdiction. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA-licensed facility (License No. 1143) at Dubai Healthcare City undergoes annual audit to maintain these standards. For further information on your data rights, please contact our Data Protection Officer.
Clinical & Logistical Metadata
| Test Name | HIV Comprehensive Panel (HIV-1/2 Ag/Ab + Western Blot + WES Susceptibility) |
| Price (AED) | 450 AED |
| Turnaround Time | Same-day report (collection Tue/Thu/Sat by 9 AM); 24–48 hours for other collection days |
| Sample Type / Matrix | Peripheral whole blood, serum, or plasma |
| Methodology Used | 4th Generation CMIA (p24 Ag/Ab) + Western Blot + Whole Exome Sequencing (WES) |
| ICD-10-CM Code | Z11.4 |
| LOINC Code | 9830-1 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians